Cutting-edge science​ in medicinal chemistry

​The Marie Skłodowska-Curie Actions (MSCA) Doctoral Network MC4DD follows an interdisciplinary and cross-sectoral approach to expand the opportunities of macrocycles as next-generation drug modalities. It brings  together 8 academic and  5 industrial groups who are experts in macrocyclic drug discovery with their competences covering the fields of organic synthesis, medicinal, high-throughput and computational chemistry, pharmacological and structural analytics, and modelling. It is coordinated by the Technische Universität Darmstadt, Germany, and offers a mobility and training platform for young scientists by means of cross-site, interdisciplinary research projects. 

Join our vibrant research community
​​
Our project offers excellent research and training in medicinal chemistry and drug discovery. We promote young researchers by offering  intersectoral and multidisciplinary mobility and training in a variety of aspects in medicinal chemistry. To complement the academic and scientific goals, we offer customized research projects, structured interdisciplinary local and network-wide transferable skills training activities, and secondments at top-ranking European universities and industry partners.

Choose from our 17 open Ph.D. positions 

We offer:
​• International PhD program
• Interdisciplinary supervision and environment
• Extracurricular seminars and workshops
• Mobility grants
• EU co-funded PhD positions for up to 4 years

Information on the position: link
​Application deadline: August 31, 2024 unless otherwise noted for specific subprojects

Please apply
- for the position in the group of Sereina Ruiniker at ETH on this link
- for the position in the group of Jan Kihlberg and Mate Erdelyi at Uppsala University on this link (deadline August 12)
- for the position in the group of Alethea Tabor at University College London  on this link (deadline September 19)

​